Publication | Closed Access

Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202)

Surgical OncologyImatinib MesylateGastrointestinal OncologyMedicineGastroenterologyPathologyGastrointestinal Stromal TumorsOncologyRadiation OncologySafety ProfileJapanese Patients